• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过球磨法获得的固体分散体作为依托度酸(一种典型的难溶性药物)的给药平台

Solid Dispersions Obtained by Ball Milling as Delivery Platform of Etodolac, a Model Poorly Soluble Drug.

作者信息

Czajkowska-Kośnik Anna, Misztalewska-Turkowicz Iwona, Wilczewska Agnieszka Zofia, Basa Anna, Winnicka Katarzyna

机构信息

Department of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2c, 15-222 Białystok, Poland.

Department of Organic Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.

出版信息

Materials (Basel). 2024 Aug 7;17(16):3923. doi: 10.3390/ma17163923.

DOI:10.3390/ma17163923
PMID:39203102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11355714/
Abstract

Poor water solubility of drugs is a limiting factor for their bioavailability and pharmacological activity. Many approaches are known to improve drug solubility, and among them, the physical method, solid dispersions (SDs), is applied. SDs are physical mixtures of a drug and a carrier, sometimes with the addition of a surfactant, which can be obtained by milling, cryomilling, spray-drying, or lyophilization processes. In this study, solid dispersions with etodolac (ETD-SDs) were prepared by the milling method using different carriers, such as hypromellose, polyvinylpyrrolidone, copovidone, urea, and mannitol. Solubility studies, dissolution tests, morphological assessment, thermal analysis, and FTIR imaging were applied to evaluate the SD properties. It was shown that the ball-milling process can be applied to obtain SDs with ETD. All designed ETD-SDs were characterized by higher water solubility and a faster dissolution rate compared to unprocessed ETD. SDs with amorphous carriers (HPMC, PVP, and PVP/VA) provided greater ETD solubility than dispersions with crystalline features (urea and mannitol). FTIR spectra confirmed the compatibility of ETD with tested carriers.

摘要

药物的低水溶性是其生物利用度和药理活性的限制因素。已知有许多方法可提高药物溶解度,其中物理方法——固体分散体(SDs)被应用。固体分散体是药物与载体的物理混合物,有时还会添加表面活性剂,可通过研磨、低温研磨、喷雾干燥或冻干工艺获得。在本研究中,采用研磨法使用不同载体(如羟丙甲纤维素、聚乙烯吡咯烷酮、共聚维酮、尿素和甘露醇)制备依托度酸固体分散体(ETD-SDs)。通过溶解度研究、溶出度试验、形态评估、热分析和傅里叶变换红外光谱成像来评估固体分散体的性质。结果表明,球磨工艺可用于制备含依托度酸的固体分散体。与未处理的依托度酸相比,所有设计的ETD-SDs均具有更高的水溶性和更快的溶出速率。含无定形载体(羟丙甲纤维素、聚乙烯吡咯烷酮和聚乙烯吡咯烷酮/醋酸乙烯酯)的固体分散体比具有结晶特性的分散体(尿素和甘露醇)具有更高的依托度酸溶解度。傅里叶变换红外光谱证实了依托度酸与测试载体的相容性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/7cb06be68a35/materials-17-03923-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/59791696fcb8/materials-17-03923-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/70de2039e84c/materials-17-03923-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/377bbd1b312a/materials-17-03923-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/2723c03e9cce/materials-17-03923-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/66f071d9903e/materials-17-03923-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/a4a5529aeebd/materials-17-03923-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/14197b306d0e/materials-17-03923-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/aa24776743d8/materials-17-03923-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/e14829f835c4/materials-17-03923-g009a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/7cb06be68a35/materials-17-03923-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/59791696fcb8/materials-17-03923-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/70de2039e84c/materials-17-03923-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/377bbd1b312a/materials-17-03923-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/2723c03e9cce/materials-17-03923-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/66f071d9903e/materials-17-03923-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/a4a5529aeebd/materials-17-03923-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/14197b306d0e/materials-17-03923-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/aa24776743d8/materials-17-03923-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/e14829f835c4/materials-17-03923-g009a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a33/11355714/7cb06be68a35/materials-17-03923-g010.jpg

相似文献

1
Solid Dispersions Obtained by Ball Milling as Delivery Platform of Etodolac, a Model Poorly Soluble Drug.通过球磨法获得的固体分散体作为依托度酸(一种典型的难溶性药物)的给药平台
Materials (Basel). 2024 Aug 7;17(16):3923. doi: 10.3390/ma17163923.
2
A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.喷雾干燥和粉碎在磺胺噻唑/聚乙烯吡咯烷酮和磺胺嘧啶/聚乙烯吡咯烷酮无定形分散体制备中的比较。
Mol Pharm. 2011 Apr 4;8(2):532-42. doi: 10.1021/mp1003674. Epub 2011 Mar 3.
3
Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.湿磨法制备依托度酸纳米混悬剂的处方和工艺参数研究。
Pharm Res. 2020 May 31;37(6):111. doi: 10.1007/s11095-020-02815-x.
4
Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.他达拉非在PVP-VA中的喷雾干燥和球磨固体分散体的直接压片的物理化学性质
Eur J Pharm Biopharm. 2016 Dec;109:14-23. doi: 10.1016/j.ejpb.2016.09.011. Epub 2016 Sep 20.
5
Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.使用喷雾干燥机制备的塞来昔布在PVP/异麦芽酮糖醇固体分散体中的异常溶解行为。
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:501-511. doi: 10.1016/j.msec.2016.11.042. Epub 2016 Nov 14.
6
Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.他达拉非固体分散体的物理化学性质——聚合物对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Biopharm. 2015 Aug;94:106-15. doi: 10.1016/j.ejpb.2015.04.031. Epub 2015 May 19.
7
Spray-dried solid dispersions containing ferulic acid: comparative analysis of three carriers, in vitro dissolution, antioxidant potential and in vivo anti-platelet effect.含阿魏酸的喷雾干燥固体分散体:三种载体的比较分析、体外溶出度、抗氧化潜力及体内抗血小板作用
Drug Dev Ind Pharm. 2016 Nov;42(11):1813-24. doi: 10.3109/03639045.2016.1173055. Epub 2016 Apr 24.
8
Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.酮洛芬与 PVP K30 和 D-甘露醇固体分散体的理化性质表征及体外溶出度研究。
Saudi Pharm J. 2013 Jan;21(1):77-84. doi: 10.1016/j.jsps.2011.12.007. Epub 2011 Dec 24.
9
Cooperative effect of polyvinylpyrrolidone and HPMC E5 on dissolution and bioavailability of nimodipine solid dispersions and tablets.聚乙烯吡咯烷酮与羟丙甲纤维素E5对尼莫地平固体分散体及片剂溶出度和生物利用度的协同作用
Asian J Pharm Sci. 2019 Nov;14(6):668-676. doi: 10.1016/j.ajps.2018.08.005. Epub 2018 Sep 18.
10
It is Possible to Achieve Tablets With Good Tabletability From Solid Dispersions - The Case of the High Dose Drug Gemfibrozil.从固体分散体中获得可压性良好的片剂是可行的 - 以高剂量药物吉非贝齐为例。
Curr Drug Deliv. 2021;18(4):460-470. doi: 10.2174/1567201817666201023121948.

本文引用的文献

1
Sweeteners Show a Plasticizing Effect on PVP K30-A Solution for the Hot-Melt Extrusion of Fixed-Dose Amorphous Curcumin-Hesperetin Solid Dispersions.甜味剂对用于热熔挤出固定剂量无定形姜黄素-橙皮素固体分散体的PVP K30溶液具有增塑作用。
Pharmaceutics. 2024 May 15;16(5):659. doi: 10.3390/pharmaceutics16050659.
2
Polyelectrolyte-based solid dispersions for enhanced dissolution and pH-Independent controlled release of sildenafil citrate.用于增强枸橼酸西地那非溶解和pH非依赖性控释的基于聚电解质的固体分散体。
Heliyon. 2023 Nov 30;9(12):e23091. doi: 10.1016/j.heliyon.2023.e23091. eCollection 2023 Dec.
3
The Study of Amorphous Kaempferol Dispersions Involving FT-IR Spectroscopy.
无定形山柰酚分散体的研究涉及傅里叶变换红外光谱法。
Int J Mol Sci. 2023 Dec 5;24(24):17155. doi: 10.3390/ijms242417155.
4
Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone.通过与氯苯那敏和聚乙烯吡咯烷酮制备共无定形固体分散体提高氯雷他定的溶解度和物理稳定性
Pharmaceutics. 2023 Oct 31;15(11):2558. doi: 10.3390/pharmaceutics15112558.
5
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
6
Amorphous Solid Dispersion of Hesperidin with Polymer Excipients for Enhanced Apparent Solubility as a More Effective Approach to the Treatment of Civilization Diseases.橙皮苷聚合物无定形固体分散体提高表观溶解度作为治疗文明病更有效的方法。
Int J Mol Sci. 2022 Dec 2;23(23):15198. doi: 10.3390/ijms232315198.
7
Current Trends on Solid Dispersions: Past, Present, and Future.固体分散体的当前趋势:过去、现在和未来
Adv Pharmacol Pharm Sci. 2022 Oct 22;2022:5916013. doi: 10.1155/2022/5916013. eCollection 2022.
8
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.难溶性药物和治疗剂的生物利用度提高技术
Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055.
9
Evolution of Solid Dispersion Technology: Solubility Enhancement Using Hydroxypropyl Methylcellulose Acetate Succinate: Myth or Reality?固体分散体技术的演变:利用羟丙甲纤维素醋酸琥珀酸酯提高溶解度:是神话还是现实?
Assay Drug Dev Technol. 2022 May-Jun;20(4):149-163. doi: 10.1089/adt.2022.016.
10
Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs.纳米颗粒策略概述:提高难溶性药物的溶解度。
Life Sci. 2022 Feb 15;291:120301. doi: 10.1016/j.lfs.2022.120301. Epub 2022 Jan 6.